A comprehensive analysis of adverse drug reactions in 2020–2023: case studies
These findings collectively highlight the critical need for personalized treatment plans and targeted monitoring. Particular attention should be directed towards high-risk groups, such as middle-aged females and patients undergoing anti-tumor therapies. By doing so, it is possible to enhance drug safety and minimize the occurrence of severe ADRs.
Authors
- Hengwei Yan
- Jinghui Zhai (ORCID: https://orcid.org/0000-0001-7707-7928)
- Jinping Zhang (ORCID: https://orcid.org/0000-0001-5537-5131)
- Jie Ma (ORCID: https://orcid.org/0000-0002-7570-9554)
- Sixi Zhang
- Huiyu Yan
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fphar.2025.1628347
- Citations
- 3
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 4.51
Funders
- People's Government of Jilin Province
- Jilin University
- Education Department of Jilin Province
- Health Commission of Jilin Province
- First Hospital of Jilin University